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Whole blood exchange transfusion as a promising 
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A 37-year-old male was referred to us about one hour after deliberate ingestion of two 3-gram aluminium phosphide 
(ALP) tablets. Three hours after admission, his blood pressure dropped to 85/55 mmHg, his heart rate increased to 120 bpm, 
O2 saturation dropped to 82 %, and the electrocardiogram showed junctional rhythm. We started whole blood exchange, 
and gross haematuria and jaundice ensued. However, his blood pressure increased, arrhythmia resolved itself, and he was 
extubated two days after the transfusion was completed. He was sent home seven days after admission completely 
symptom-free. We believe this treatment may be successfully applied in ALP-poisoned patients.
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In some southern Asian countries pesticide poisonings 
account for over 50 % of all poisonings, with fatality rates 
as high as 70 % (1, 2). Among them, aluminium phosphide 
(ALP) poisoning has been the number one cause of death 
over the last two decades, especially in Iran (3, 4). This 
cardiovascular toxin is even more common than 
cardiovascular drugs in overdosed patients admitted to 
intensive care units (ICUs) (5).
Although its fatality rates are as high as 70 %, there is 
no antidote for ALP toxicity (6). Several treatments have 
been suggested, the most aggressive of which are intra-
aortic balloon pump and extracorporeal membrane 
oxygenation (ECMO) (7, 8). However, such treatments are 
extremely invasive, need experienced people to perform 
them, and are not readily available.
The mechanism of ALP toxicity is non-competitive 
blockage of cytochrome C oxidase, which inhibits oxidative 
phosphorylation and cellular respiration while it activates 
peroxide radicals. Phosphine can also inhibit catalase and 
deplete glutathione, which, in turn, results in cellular wall 
and canal dysfunction (6). Zamani and Mehrpour (9) and 
Hassanian-Moghaddam et al. (10) pointed to the role of 
affected erythrocytes in the mechanism of toxicity and death 
in ALP poisoning and Zamani and Mehrpour were the first 
to suggest blood exchange as an approach to treating ALP 
poisoning (9).
CASE REPORT
A 37-year-old male was referred to us about an hour 
after deliberate ingestion of two 3-gram ALP tablets 
(containing 56 % of ALP). He had a history of suicide 
attempt by cyanide. He mentioned that he had vomited five 
minutes after the ingestion of the tablets. On presentation 
his vital signs were normal and O2 saturation was 98 %. 
CO oximetry showed a 26 % CO content.
The patient was admitted to the medical toxicology ICU 
with the diagnosis of ALP poisoning. Since the patient had 
vomited and arrived late after ingestion, gastric 
decontamination was not done.
Almost three hours after admission, his blood pressure 
dropped to 85/55 mmHg, his heart rate increased to 
120 bpm, and O2 saturation dropped to 82 % with no 
response to  convent ional  t reatments  (6) .  The 
electrocardiogram showed junctional rhythm. The patient 
was therefore intubated and put on our routine treatment 
including calcium gluconate, magnesium sulphate, vitamin 
E, N-acetyl cysteine, and glucose-insulin (5, 6, 10).
According to the risk assessment flowchart of our centre, 
which is applied in case of suspected ALP ingestions, any 
carboxyhaemoglobin (SpCO) of 25 % or more can lead to 
death irrespective of the clinical findings on presentation 
(11). The attending physician therefore decided that the 
patient required whole blood exchange and ordered 
haematology consult. The patient’s next of kin gave written 
consent to exchange transfusion after having been fully 
informed about the fatal nature of the poisoning and the 
unknown effects of the treatment. Having secured 10 units 
of red blood cells (RBCs), 10 units of fresh frozen plasma 
(FFP), and 10 units of platelets, the haematologist started 
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whole blood exchange transfusion. One RBC unit was given 
every 30 min and 500 mL of the affected blood released 
from another venous line, followed by administration of 
one unit of FFP and one unit of platelets. To prevent 
common complications of whole blood exchange including 
hypocalcaemia, hypoglycaemia, and hypo or hyperkalaemia, 
blood glucose and electrolytes were checked every four 
hours and administered if indicated. Prothrombin time (PT), 
international normalised ratio (INR), partial thromboplastin 
time (PTT), and complete blood count (CBC) were checked 
every six hours, and platelets were given when they dropped 
below 150,000 per microlitre.
The patient developed gross haematuria almost three 
hours into the transfusion, mandating a 12-hour pause in 
RBC administration. Instead, he received serum therapy, 
vesicular irrigation, four units of FFP, and five units of 
platelets. Throughout the pause, the patient remained 
symptom-free. One day after the exchange transfusion was 
started, he developed fever and started receiving leukocyte-
free blood transfusion.
The whole blood exchange transfusion, including the 
12-hour pause, lasted almost 20 h, after which time the 
patient’s fever resolved itself. However, on the third day, 
the patient developed jaundice, with total and indirect 
bilirubin of 4.5 and 3.8 mg dL-1, respectively. During the 
exchange transfusion SpCO increased to 47 % but gradually 
dropped to normal 48 h after the exchange was completed. 
Although the patient had difficulty receiving food by gavage 
at first (which was overcome with metoclopramide 
treatment), his blood pressure increased, the arrhythmia 
resolved itself, and he was extubated two days after the 
exchange was completed. He remained completely 
symptom-free, started oral feeding regimen one day later, 
and was sent home after psychiatric evaluation on the 
seventh day from admission. On discharge, all haematological 
lab tests were normal.
DISCUSSION
High level of CO in CO-oximetry, hypotension, and 
cardiac arrhythmia are all indicators of severe poisoning 
(11). Our patient developed severe complications even 
though he received anti-oxidant treatment. ECMO was not 
available, and we thought we needed to do something to 
stop their progression before it was too late.
In 2012, Zamani and Mehrpour (9) suggested that 
glucose-6-phosphate dehydrogenase G6PD deficiency 
could have a protective role in ALP poisoning, as it leads 
to the breakdown or RBCs affected by oxidative stress and 
extra-mitochondrial release of free oxygen radicals in ALP 
poisoning. Therefore, they suggested, removing the affected 
RBCs with whole blood exchange be beneficial for ALP-
poisoned patients.
A study in rats showed that G6PD deficiency, induced 
by 6-aminonicotinamide, had a significant protective effect 
on the hepatocytes (12). A similar study showed that fresh 
red blood cell transfusion improved metabolic acidosis and 
increased the survival of ALP-poisoned rats (13). This led 
us to assume that the elimination of damaged RBCs by any 
method could improve treatment outcome.
Although the exchange transfusion in our patient was 
associated with haemolysis, jaundice, fever, and haematuria, 
we believe that it saved his life, as no other treatment than 
conservative anti-oxidant management was available. 
Haematuria developed almost three hours into the exchange 
transfusion. Having ruled out the ABO incompatibility 
reactions, we believe that this acute haemolytic transfusion 
reaction is related to incompatibility reactions to minor 
antibodies.
Although the exact mechanism of phosphine toxicity 
remains unclear, it has been suggested to inhibit 
cytochrome-C oxidase in platelets, as well (14). Therefore, 
whole blood exchange may be a better treatment than RBC 
exchange. Considering the 30-70 % death rate of ALP 
poisoning (6) and less than 10 % death risk of blood 
exchange (15), we believe that this treatment is reasonable 
in high-risk patients. Further investigation is needed to test 
this hypothesis.
Even though we could not test our patient for G6PD 
deficiency, because this test was not available at our centre, 
we believe this does not undermine our findings, because 
G6PD deficiency would not have affected the outcome of 
whole blood exchange. Our search across Google Scholar, 
Scopus, and PubMed, did not produce any other article 
suggesting the similar approach, and we hope that future 
studies will bring more answers about this approach to 
managing ALP poisoning. In the meanwhile, elimination 
of free oxygen radicals and affected RBCs with whole blood 
exchange transfusion may save a few more lives.
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Zamjena pune krvi kao obećavajući način liječenja otrovanja aluminijevim fosfidom
Muškarac star 37 godina primljen je u naš centar za otrovanja približno jedan sat nakon što je namjerno progutao dvije 
3-gramske tablete aluminijeva fosfida. Tri sata poslije krvni mu je tlak pao na 85/55 mmHg, broj otkucaja srca porastao 
na 120 u minuti, a zasićenje kisikom palo na 82 %. Nije odgovarao na konvencionalno liječenje. Na elektrokardiogramu 
se vidio nodalni ritam. Započet je postupak zamjene pune krvi, što je dovelo do pojave krvi u mokraći i do žutice. Krvni 
je tlak nakon postupka porastao, aritmija je prestala, a pacijent je ekstubiran dva dana nakon svršetka zamjene krvi. 
Otpušten je kući bez ikakvih simptoma sedam dana nakon prijema. Vjerujemo da bi ovakav način obrade mogao biti 
uspješan u liječenju otrovanja aluminijevim fosfidom.
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